Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations
Nephron Physiology · 24.10.2014 · 128 (3-4) · 55-61
DOI: 10.1159/000366225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephron Physiology, online erschienen am 24.10.2014. Verfasst von Arabella Simpkin und 19 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Medical Research Council, Wellcome Trust, Department of Health.
Abstract (Originalsprache)
Background/Aims: Donohue and Rabson-Mendenhall syndrome are rare autosomal recessive disorders caused by mutations in the insulin receptor gene, INSR. Phenotypic features include extreme insulin resistance, linear growth retardation, paucity of fat and muscle, and soft tissue overgrowth. The insulin receptor is also expressed in the kidney, where animal data suggest it plays a role in glomerular function and blood pressure (BP) regulation, yet such a role in the human kidney is untested. Patients with biallelic INSR mutations provide a rare opportunity to ascertain its role in man.
Methods
Retrospective review of patients with INSR mutations. Data for BP, renal imaging, plasma creatinine and electrolyte levels, as well as urine protein, albumin and calcium excretion were sought from the treating clinicians.
Results
From 33 patients with INSR mutations, data were available for 17 patients. Plasma creatinine was low (mean ± SD: 25 ± 9 μmol/l) and mean plasma electrolyte concentrations were within the normal range (n = 13). Systolic BP ranged between the 18th and 91st percentile for age, sex, height and weight (n = 9; mean ± SD: 49 ± 24). Twenty-four-hour urinary calcium data were available from 10 patients and revealed hypercalciuria in all (mean ± SD: 0.32 ± 0.17 mmol/kg/day; normal
Schlagwörter
Stichwörter der Autor:innen
Förderung
- Medical Research Council
- Wellcome Trust
- Department of Health
Zitieren
APA
Simpkin, A., Cochran, E., Cameron, F., Dattani, M., de Bock, M., Dunger, D. B., Forsander, G., Guran, T., Harris, J., Isaac, I., Hussain, K., Kleta, R., Peters, C., Tasic, V., Williams, R., Yap Kok Peng, F., O''Rahilly, S., Gorden, P., Semple, R. K., & Bockenhauer, D. (2014). Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations. Nephron Physiology, 128(3-4), 55-61. https://doi.org/10.1159/000366225
Vancouver
Simpkin A, Cochran E, Cameron F, Dattani M, de Bock M, Dunger DB, et al. Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations. Nephron Physiology. 2014;128(3-4):55-61. doi:10.1159/000366225
BibTeX
@article{Simpkin2014,
author = {Simpkin, Arabella and Cochran, Elaine and Cameron, Fergus and Dattani, Mehul and de Bock, Martin and Dunger, David B and Forsander, Gun and Guran, Tulay and Harris, Julie and Isaac, Iona and Hussain, Khalid and Kleta, Robert and Peters, Catherine and Tasic, Velibor and Williams, Rachel and Yap Kok Peng, Fabian and O''Rahilly, Stephan and Gorden, Philipp and Semple, Robert K and Bockenhauer, Detlef},
title = {Insulin Receptor and the Kidney: Nephrocalcinosis in Patients with Recessive INSR Mutations},
journal = {Nephron Physiology},
year = {2014},
volume = {128},
number = {3-4},
pages = {55--61},
doi = {10.1159/000366225}
}
EUVIMED